250 related articles for article (PubMed ID: 31628977)
1. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-conjugated pluronic niosomes as a new drug delivery system for anticancer therapy.
Tavano L; Muzzalupo R; Mauro L; Pellegrino M; Andò S; Picci N
Langmuir; 2013 Oct; 29(41):12638-46. PubMed ID: 24040748
[TBL] [Abstract][Full Text] [Related]
4. Further Evolution of Multifunctional Niosomes Based on Pluronic Surfactant: Dual Active Targeting and Drug Combination Properties.
Tavano L; Mauro L; Naimo GD; Bruno L; Picci N; Andò S; Muzzalupo R
Langmuir; 2016 Sep; 32(35):8926-33. PubMed ID: 27504856
[TBL] [Abstract][Full Text] [Related]
5. Application of Box-Behnken Design in the Preparation, Optimization, and In Vitro Evaluation of Self-Assembly-Based Tamoxifen- and Doxorubicin-Loaded and Dual Drug-Loaded Niosomes for Combinatorial Breast Cancer Treatment.
Kulkarni P; Rawtani D
J Pharm Sci; 2019 Aug; 108(8):2643-2653. PubMed ID: 30905701
[TBL] [Abstract][Full Text] [Related]
6. A new formulation of hydrophobin-coated niosome as a drug carrier to cancer cells.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Lohrasbi-Nejad A; Nematollahi MH
Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110975. PubMed ID: 32487392
[TBL] [Abstract][Full Text] [Related]
7. Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin.
Pawar S; Vavia P
J Drug Target; 2016; 24(1):68-79. PubMed ID: 26152812
[TBL] [Abstract][Full Text] [Related]
8. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
Khan MI; Madni A; Peltonen L
Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel loaded niosome nanoparticle formulation prepared via reverse phase evaporation method: an in vitro evaluation.
Zarei M; Norouzian D; Honarvar B; Mohammadi M; Shamabadi HE; Akbarzadeh A
Pak J Biol Sci; 2013 Mar; 16(6):295-8. PubMed ID: 24498794
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes.
Barani M; Hajinezhad MR; Sargazi S; Rahdar A; Shahraki S; Lohrasbi-Nejad A; Baino F
J Mater Sci Mater Med; 2021 Dec; 32(12):147. PubMed ID: 34862910
[TBL] [Abstract][Full Text] [Related]
12. Theranostic niosomes for direct intratumoral injection: marked enhancement in tumor retention and anticancer efficacy.
Nowroozi F; Dadashzadeh S; Soleimanjahi H; Haeri A; Shahhosseini S; Javidi J; Karimi H
Nanomedicine (Lond); 2018 Sep; 13(17):2201-2219. PubMed ID: 29993311
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonic Processing Technique as a Green Preparation Approach for Diacerein-Loaded Niosomes.
Khan MI; Madni A; Hirvonen J; Peltonen L
AAPS PharmSciTech; 2017 Jul; 18(5):1554-1563. PubMed ID: 27604883
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of Paclitaxel-Loaded PEGylated Niosomes Composed of Sorbitan Esters.
Hosokawa M; Ito S; Noda K; Kono Y; Ogawara KI
Biol Pharm Bull; 2023; 46(10):1479-1483. PubMed ID: 37779050
[TBL] [Abstract][Full Text] [Related]
15. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy.
Safari Sharafshadeh M; Tafvizi F; Khodarahmi P; Ehtesham S
Int J Biol Macromol; 2023 Apr; 235():123686. PubMed ID: 36801304
[TBL] [Abstract][Full Text] [Related]
16. The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models.
Uchegbu IF; Double JA; Kelland LR; Turton JA; Florence AT
J Drug Target; 1996; 3(5):399-409. PubMed ID: 8866659
[TBL] [Abstract][Full Text] [Related]
17. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
18. Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Nematollahi MH
Daru; 2018 Sep; 26(1):11-17. PubMed ID: 30159762
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
20. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
